2022 USPSTF建议声明:原发性开角型青光眼的筛查

2022-05-24 美国预防医学工作组 JAMA

2022年5月,美国预防医学工作组(USPSTF)更新发布了原发性开角型青光眼的筛查建议声明。本文是对2013版建议声明的更新。专家组通过总结当前证据指出当前的证据不足平衡评估原发性开角型青光眼筛查的

中文标题:

2022 USPSTF建议声明:原发性开角型青光眼的筛查

英文标题:

Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement

发布机构:

美国预防医学工作组

发布日期:

2022-05-24

简要介绍:

2022年5月,美国预防医学工作组(USPSTF)更新发布了原发性开角型青光眼的筛查建议声明。本文是对2013版建议声明的更新。专家组通过总结当前证据指出当前的证据不足平衡评估原发性开角型青光眼筛查的利弊。

相关资料下载:
[AttachmentFileName(sort=1, fileName=jama_mangione_2022_us_220011_1652813391.43919.pdf)] GetToolGuiderByIdResponse(projectId=1, id=44aa71c002a518a1, title=2022 USPSTF建议声明:原发性开角型青光眼的筛查, enTitle=Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement, guiderFrom=JAMA, authorId=0, author=, summary=2022年5月,美国预防医学工作组(USPSTF)更新发布了原发性开角型青光眼的筛查建议声明。本文是对2013版建议声明的更新。专家组通过总结当前证据指出当前的证据不足平衡评估原发性开角型青光眼筛查的, cover=https://img.medsci.cn/20220526/1653580747592_1608702.png, journalId=0, articlesId=null, associationId=121, associationName=美国预防医学工作组, associationIntro=由预防和循证医学的非联邦专家和初级保健提供者(如内科,儿科医生,家庭医生,妇科/产科医生,护士和健康行为专家)组成的非联邦小组。为初级保健医生和卫生系统提供指导意见和科学证据。, copyright=0, guiderPublishedTime=Tue May 24 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年5月,美国预防医学工作组(USPSTF)更新发布了原发性开角型青光眼的筛查建议声明。本文是对2013版建议声明的更新。专家组通过总结当前证据指出当前的证据不足平衡评估原发性开角型青光眼筛查的利弊。</span></p>, tagList=[TagDto(tagId=56579, tagName=原发性开角型青光眼)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11336, appHits=31, showAppHits=0, pcHits=149, showPcHits=11305, likes=0, shares=1, comments=1, approvalStatus=1, publishedTime=Fri May 27 15:33:00 CST 2022, publishedTimeString=2022-05-24, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri May 27 00:05:25 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 22:24:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=jama_mangione_2022_us_220011_1652813391.43919.pdf)])
jama_mangione_2022_us_220011_1652813391.43919.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1225088, encodeId=3e6a122508896, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:32:17 CST 2022, time=2022-06-07, status=1, ipAttribution=)]
    2022-06-07 眼科芳

    学习了

    0